First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase Ib/II JAVELIN chemotherapy medley study

Wheatley, D.A. orcid.org/0000-0002-1919-5114, Berardi, R. orcid.org/0000-0002-9529-2960, Climent Duran, M.A. orcid.org/0000-0001-7523-0212 et al. (17 more authors) (2024) First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase Ib/II JAVELIN chemotherapy medley study. Cancer Research Communications, 4 (6). pp. 1609-1619. ISSN 2767-9764

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 The Authors; Published by the American Association for Cancer Research. This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. (http://creativecommons.org/licenses/by/4.0/)

Keywords: Humans; Antibodies, Monoclonal, Humanized; Female; Middle Aged; Male; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Carboplatin; Gemcitabine; Deoxycytidine; Cisplatin; Pemetrexed; Adult; Carcinoma, Transitional Cell; Aged, 80 and over; Urologic Neoplasms
Dates:
  • Published: 28 June 2024
  • Published (online): 28 June 2024
  • Accepted: 24 April 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 07 Aug 2024 12:05
Last Modified: 07 Aug 2024 12:05
Status: Published
Publisher: American Association for Cancer Research (AACR)
Refereed: Yes
Identification Number: 10.1158/2767-9764.crc-23-0459
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Export

Statistics